Aerie Pharmaceuticals Inc

AMERIPRISE FINANCIAL INC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

116,422

Value ($000)

1,762

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	1,762	0.0%	116,422	9/30/2022
2022 Q2	8/15/2022	10,640	0.0%	1,419,176	6/30/2022
2022 Q1	5/16/2022	12,897	0.0%	1,418,305	3/31/2022
2021 Q4	2/14/2022	14,236	0.0%	2,028,787	12/31/2021
2021 Q3	11/15/2021	18,484	0.0%	1,621,330	9/30/2021
2021 Q2	8/16/2021	25,132	0.0%	1,569,744	6/30/2021
2021 Q1	5/17/2021	28,433	0.0%	1,591,132	3/31/2021
2020 Q4	2/12/2021	18,474	0.0%	1,367,484	12/31/2020
2020 Q3	11/16/2020	13,090	0.0%	1,112,130	9/30/2020
2020 Q2	8/14/2020	12,343	0.0%	836,075	6/30/2020
2020 Q1	5/15/2020	15,724	0.0%	1,166,021	3/31/2020
2019 Q4	2/14/2020	26,856	0.0%	1,111,936	12/31/2019